ASPEN PHARMACARE HOLDINGS LIMITED - Changes to the Aspen Board Committees
Changes to the Aspen Board Committees
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)
CHANGES TO THE ASPEN BOARD (“THE BOARD”) COMMITTEES
Following the resignation of Ms Babalwa Ngonyama as a director of the Board, the Board hereby
announces the below changes to its committees:
Audit & Risk Committee
- Appointment of Mr B J Kruger as the chairperson
- Appointment of Ms Y G Muthien as a member
Social & Ethics Committee
- Stepping down of Mr B J Kruger as the chairperson, and remaining a member of the committee
- Appointment of Ms Y G Muthien as the chairperson
Further announcements will be made in respect of the appointment of an additional director to the Board
to strengthen the Audit & Risk Committee and to ensure that Aspen meets its diversity requirements.
Durban
14 June 2023
Sponsor
Investec Bank Limited
Date: 14-06-2023 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
